Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Latest round
Venture round
Mar 2026 · 6 mo ago
Team
51-200
employees, estimated range
Grants
1
1 grant · CORDIS
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 30 Raised a round Venture round Jul 11, 2025 Raised a round Venture round Mar 28, 2025 Raised a round Venture round Mar 26, 2024 Raised a round Venture round Aug 9, 2023 Raised a round Venture round Aug 25, 2021 Raised a round Venture round Oct 1, 2020 Won a grant CORDIS Mar 10, 2020 Raised a round Venture round May 23, 2019 Raised a round Venture round Aug 28, 2018 Raised a round Venture round Mar 2, 2017 Founded per the company register
Funding rounds
RoundDateAmountInvestorsSource
Venture round Mar 2026 — — find-and-update.company-information.service.gov.uk
Venture round Jul 2025 — — find-and-update.company-information.service.gov.uk
Venture round Mar 2025 — — find-and-update.company-information.service.gov.uk
Venture round Mar 2024 — — find-and-update.company-information.service.gov.uk
Venture round Aug 2023 — — find-and-update.company-information.service.gov.uk
Venture round Aug 2021 — — find-and-update.company-information.service.gov.uk
Grant Oct 2020 — — CORDIS
Venture round Mar 2020 — — find-and-update.company-information.service.gov.uk
Venture round May 2019 — — find-and-update.company-information.service.gov.uk
Venture round Aug 2018 — — find-and-update.company-information.service.gov.uk
Registers and programsofficial lists and records that name the company
Legal entity ENTEROBIOTIX LIMITED Companies House
Registered 2 Mar 2017
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Retension PharmaceuticalsVenture round $12.3M · 18 mo ago • Founded 2023 • 51-200 employees
Retension Pharmaceuticals is a clinical-stage biopharmaceutical company developing RTN-001 and next-generation therapies for uncontrolled…
AusperbioSeries C $120M · 1 mo ago
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing…
VeradermicsConvertible Note $30M · 5 mo ago • Founded 2020
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company.
Stelexis BioSciences is a clinical-stage biopharmaceutical company created to accelerate novel treatments that aim to eradicate…
Opna BioFounded 2020 • 51-200 employees
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics. The…
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory…

Visa sponsorship

  • United Kingdom · Licensed UK visa sponsor (Skilled Worker)

Visa details by country

Overview

EnteroBiotix is a clinical-stage biopharmaceutical company developing best-in-class full-spectrum microbial therapeutics.

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Edinburgh United Kingdom
HQ
Bellshill United Kingdom
Regional office
Number 2® donor programme
Unit 2.3, Western Campus, Strathclyde Business Park, Bellshill, Lanarkshire, ML4 3PU, Scotland
company site

Financials

Latest round
Venture - Series Unknown
Funding rounds
10
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 — Details
Venture - Series Unknown 2025 — Details
Venture - Series Unknown 2025 — Details
Venture - Series Unknown 2024 — Details
Venture - Series Unknown 2023 — Details
Venture - Series Unknown 2021 — Details
Grant 2020 — Details
Venture - Series Unknown 2020 — Details
Venture - Series Unknown 2019 — Details
Venture - Series Unknown 2018 — Details